Pharmaceutical giant Pfizer has received U.S. approval for a gene therapy against a form of hemophilia, a rare and inherited blood clotting disorder, the company said Friday. Beqvez, which is given as a single intravenous infusion, was shown in a clinical trial of 45 people to be better at (...)
Site référencé: Raw Story
Raw Story
CBS News anchor delivers blistering takedown as company caves to Trump
4/07/2025
'Stunning admission' : CNN host floored as Trump's call doesn't go as planned
4/07/2025
Top Trump DOJ prosecutor under investigation for possible hush money scheme
4/07/2025
GOP rep pushes to carve Trump into Mt. Rushmore despite 'preservation questions'
4/07/2025
Dr Phil sues televangelist network for 'sabotaging' his bankrupt media company
4/07/2025
'He’s a rhinoceros sir' : MAGA loyalists rage at Trump for backing GOP rep
4/07/2025
